USPTO serial 90028708
OXFORD HEARTBEAT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- INGRAM, KYLE G
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with OXFORD HEARTBEAT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard S. Finkelstein
Richard S. Finkelstein RC TRADEMARK COMPANY, LLCP.O. BOX 940BROOKFIELD, CT 06804United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for use in the simulation of blood flow; Downloadable computer software for use in the simulation of blood flow in relation to vessel and arterial diseases and abnormalities; Downloadable computer software for use in the simulation of blood flow in relation to vessel and arterial diseases and abnormalities for use in the medical and surgical field; Downloadable computer software for use in the simulation of blood flow in relation to vessel and arterial diseases and abnormalities for use in the veterinary field; Downloadable computer software for enabling the storage, retrieval, transmission and processing of data and information; Downloadable computer software for enabling the storage, retrieval, transmission and processing of data and information for medical purposes; Downloadable computer software for use in decision support systems and real time surgery support and visualisation; downloadable computer software for use in medical decision support systems; Downloadable computer software for medical image processing, anatomy visualisation and analysis, diagnosis and treatment simulations, predictions and suggestions for use in machine learning; Downloadable computer software for medical image processing, anatomy visualisation and analysis, diagnosis and treatment simulations, predictions and suggestions for use in machine learning for medical purposes; Downloadable computer software applications for the provision of access to advice and information; Downloadable computer software applications for the provision of access to medical advice and information; Downloadable computer software for use in creating computer generated models and simulations; Downloadable computer software for use in creating computer generated models and simulations of medical data; Virtual reality models being downloadable virtual reality software for use in medical teaching; Medical diagnostic simulators for use as teaching aids for surgeries for the treatment of blood vessel and arterial diseases and abnormalities; Electronic data processing apparatus; headmounted display apparatus, namely, Head-mounted video displays; computer display screens; scanners being data processing apparatus; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereof | ACTIVE | — |
| 035 | Compilation of information into computer databases; Data processing services; Data processing services in the medical and surgical field; Data processing services in the veterinary field; Database management; Database management in the medical field; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereof | ACTIVE | — |
| 042 | Computer modelling and design of computer-simulated models of human anatomy and treatment options related to vessel and arterial diseases and abnormalities; Computer modelling and design of computer-simulated models of human anatomy and treatment options related to vessel and arterial diseases and abnormalities including for the purposes of diagnostics, pre-operative planning and real time surgery support and visualization; Design and development of medical apparatus, namely, design and testing for new product development; Design and development of medical technology, namely, design and testing for new product development; Medical device design services being new product design services; Simulations of the deployment and manual manipulation of vascular medical devices being simulation of manual manipulation by clinicians in the nature of medical research services; Custom design of medical devices for others being new product design services; Software as a Service (SAAS) services featuring software for medical image processing, anatomy visualisation and analysis, diagnosis and treatment simulations, predictions and suggestions for medical use in the field of vascular and arterial diseases and abnormalities and their associated treatments; Software as a Service (SAAS) services featuring software for simulation of blood flow as relevant to vascular and arterial diseases and abnormalities and their associated treatments for use in the medical field; Software as a Service (SAAS) services featuring software for Simulation of blood flow as relevant to vascular and arterial diseases and abnormalities and their associated treatments for use in the veterinary field; Virtualizing surgical procedures, namely, services in the nature of computer modelling of surgical procedures; Computer modelling and simulating of human, biological and synthetic organs and fluids, being computer modelling services; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereof | ACTIVE | — |
| 044 | Providing on-line information in the medical field being the provision of medical information; Medical services; Minimally invasive surgical services; Rental of medical apparatus and instruments; Surgery; Veterinary services; Medical analysis services relating to patient treatment, namely, web-based vascular and arterial analysis services for medical diagnostic and treatment purposes; Medical and surgical diagnostic services, namely, medical diagnosis of Vascular and arterial disorders and abnormalities; None of the aforesaid for use in connection with clinical communications software to optimize communication and collaboration and to streamline clinical workflows within healthcare facilities, healthcare business entities, and for healthcare providers; all of the aforesaid for use in medical devices and technology applications, namely, for medical and surgical processes and implementation thereof | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford Heartbeat Ltd
- Other trademarks owned by Oxford Heartbeat Ltd
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named OXFORD HEARTBEAT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 9, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 3, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 11, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 11, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 11, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 11, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 11, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 23, 2026 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jan 23, 2026 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Jan 23, 2026 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jan 23, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 23, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 23, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 8, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 8, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 8, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 4, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 4, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 4, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 4, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 7, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 5, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 5, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 5, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 22, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 22, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 22, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 22, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2024 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jan 18, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jan 12, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2024 | ALIE | ASSIGNED TO LIE | — |
| Jun 2, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 2, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 2, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 11, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 29, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 29, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 29, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 29, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 29, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 29, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 8, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 8, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 8, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 5, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 13, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 15, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 13, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 13, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 13, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 14, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 3, 2020 | NWAP | NEW APPLICATION ENTERED | — |